Patents by Inventor Hiroki Haniuda

Hiroki Haniuda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition
    Patent number: 11951103
    Abstract: The present invention relates to a therapeutic agent for an ophthalmic disease comprising a vascular endothelial growth factor (VEGF) receptor inhibitor or an epidermal growth factor (EGF) receptor inhibitor in a nanoparticle form, having a property to be retained in a posterior eye tissue when systemically administered.
    Type: Grant
    Filed: November 30, 2020
    Date of Patent: April 9, 2024
    Assignee: KYOWA KIRIN CO., LTD.
    Inventors: Hiroki Haniuda, Sachiko Enokizono, Tomoyuki Nakazato, Takuya Tokuda, Norie Fujiki
  • PHARMACEUTICAL COMPOSITION
    Publication number: 20210077481
    Abstract: The present invention relates to a therapeutic agent for an ophthalmic disease comprising a vascular endothelial growth factor (VEGF) receptor inhibitor or an epidermal growth factor (EGF) receptor inhibitor in a nanoparticle form, having a property to be retained in a posterior eye tissue when systemically administered.
    Type: Application
    Filed: November 30, 2020
    Publication date: March 18, 2021
    Applicant: Kyowa Kirin Co., Ltd.
    Inventors: Hiroki HANIUDA, Sachiko ENOKIZONO, Tomoyuki NAKAZATO, Takuya TOKUDA, Norie FUJIKI
  • Pharmaceutical composition
    Patent number: 10894043
    Abstract: The present invention relates to a therapeutic agent for an ophthalmic disease comprising a vascular endothelial growth factor (VEGF) receptor inhibitor or an epidermal growth factor (EGF) receptor inhibitor in a nanoparticle form, having a property to be retained in a posterior eye tissue when systemically administered.
    Type: Grant
    Filed: September 13, 2017
    Date of Patent: January 19, 2021
    Assignee: KYOWA KIRIN CO., LTD.
    Inventors: Hiroki Haniuda, Sachiko Enokizono, Tomoyuki Nakazato, Takuya Tokuda, Norie Fujiki
  • PHARMACEUTICAL COMPOSITION
    Publication number: 20190365737
    Abstract: The present invention relates to a therapeutic agent for an ophthalmic disease comprising a vascular endothelial growth factor (VEGF) receptor inhibitor or an epidermal growth factor (EGF) receptor inhibitor in a nanoparticle form, having a property to be retained in a posterior eye tissue when systemically administered.
    Type: Application
    Filed: September 13, 2017
    Publication date: December 5, 2019
    Applicant: Kyowa Hakko Kirin Co., Ltd.
    Inventors: Hiroki HANIUDA, Sachiko ENOKIZONO, Tomoyuki NAKAZATO, Takuya TOKUDA, Norie FUJIKI
  • PHARMACEUTICAL PREPARATION
    Publication number: 20170354615
    Abstract: The present invention provides a pharmaceutical preparation comprising a layer-by-layer thin film that is produced by alternately layering a polycation and a polyanion, and a drug loaded onto the layer-by-layer thin film. As a result, a pharmaceutical preparation with a prolonged duration of drug action with a single dose is provided.
    Type: Application
    Filed: July 27, 2017
    Publication date: December 14, 2017
    Applicants: NANOTHETA CO, LTD., TORAY INDUSTRIES, INC.
    Inventors: Shinji TAKEOKA, Kenji KASHIWAGI, Toshinori FUJIE, Akihiro SAITO, Hiroki HANIUDA
  • PHARMACEUTICAL PREPARATION
    Publication number: 20140086973
    Abstract: The present invention provides a pharmaceutical preparation comprising a layer-by-layer thin film that is produced by alternately layering a polycation and a polyanion, and a drug loaded onto the layer-by-layer thin film. As a result, a pharmaceutical preparation with a prolonged duration of drug action with a single dose is provided.
    Type: Application
    Filed: March 23, 2012
    Publication date: March 27, 2014
    Applicant: NANOTHETA CO, LTD.
    Inventors: Shinji Takeoka, Kenji Kashiwagi, Toshinori Fujie, Akihiro Saito, Hiroki Haniuda